Massachusetts Financial Services
PAHC icon

Massachusetts Financial Services’s Phibro Animal Health PAHC Stock Holding History

Massachusetts Financial Services’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$710K Sell
22,613
-6,744
-23% -$285K ﹤0.01% 923
2026
Q1 		$1.62M Sell
29,357
-32,178
-52% -$1.53M ﹤0.01% 810
2025
Q4 		$2.3M Sell
61,535
-12,117
-16% -$492K ﹤0.01% 777
2025
Q3 		$2.98M Sell
73,652
-21,575
-23% -$713K ﹤0.01% 736
2025
Q2 		$2.43M Buy
95,227
+1,181
+1% +$25.8K ﹤0.01% 749
2025
Q1 		$2.01M Sell
94,046
-2,153
-2% -$48.1K ﹤0.01% 757
2024
Q4 		$2.02M Buy
+96,199
New +$2.23M ﹤0.01% 759
2023
Q3 		– Sell
-51,019
Closed -$699K – 864
2023
Q2 		$699K Sell
51,019
-1,201
-2% -$17.2K ﹤0.01% 773
2023
Q1 		$800K Sell
52,220
-1,477
-3% -$22.6K ﹤0.01% 780
2022
Q4 		$720K Buy
53,697
+1,140
+2% +$15.3K ﹤0.01% 797
2022
Q3 		$698K Sell
52,557
-477
-0.9% -$8.24K ﹤0.01% 797
2022
Q2 		$1.01M Buy
53,034
+266
+0.5% +$5.04K ﹤0.01% 770
2022
Q1 		$1.05M Buy
52,768
+547
+1% +$11K ﹤0.01% 796
2021
Q4 		$1.07M Sell
52,221
-1,057
-2% -$22.6K ﹤0.01% 813
2021
Q3 		$1.15M Sell
53,278
-8,625
-14% -$208K ﹤0.01% 824
2021
Q2 		$1.79M Buy
61,903
+530
+0.9% +$14.3K ﹤0.01% 793
2021
Q1 		$1.5M Sell
61,373
-7,272
-11% -$164K ﹤0.01% 803
2020
Q4 		$1.33M Sell
68,645
-685
-1% -$12.6K ﹤0.01% 776
2020
Q3 		$1.21M Sell
69,330
-2,717
-4% -$58K ﹤0.01% 766
2020
Q2 		$1.89M Sell
72,047
-1,836
-2% -$45.6K ﹤0.01% 691
2020
Q1 		$1.79M Buy
73,883
+11,693
+19% +$286K ﹤0.01% 694
2019
Q4 		$1.54M Sell
62,190
-6,709
-10% -$156K ﹤0.01% 736
2019
Q3 		$1.47M Buy
68,899
+7,688
+13% +$211K ﹤0.01% 751
2019
Q2 		$1.95M Buy
61,211
+8,532
+16% +$268K ﹤0.01% 735
2019
Q1 		$1.74M Buy
52,679
+10,680
+25% +$332K ﹤0.01% 736
2018
Q4 		$1.35M Buy
41,999
+11,951
+40% +$451K ﹤0.01% 746
2018
Q3 		$1.29M Buy
+30,048
New +$1.42M ﹤0.01% 764

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Massachusetts Financial Services's PAHC Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Phibro Animal Health (PAHC) stake by 23% in Q2 2026, selling an estimated $285K and leaving 22,613 shares worth $710K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

Massachusetts Financial Services first reported a position in PAHC in Q3 2018 and has held it in 27 quarters since. The position peaked at $2.98M in Q3 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Massachusetts Financial Services held 22,613 shares of Phibro Animal Health worth $710K as of Q2 2026.
  • Massachusetts Financial Services sold 6,744 Phibro Animal Health shares in Q2 2026, an estimated $285K.
  • Phibro Animal Health made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #923 holding.
  • Massachusetts Financial Services first reported a position in Phibro Animal Health in Q3 2018 and has held it in 27 quarters since.
  • Massachusetts Financial Services's Phibro Animal Health position peaked at $2.98M in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.